Results 81 to 90 of about 5,950 (190)

Recent advances: rheumatology [PDF]

open access: yes, 2000
No abstract ...
Madhok, R., Kerr, H., Capell, H.A.
core   +4 more sources

Design of, and first data from, PATRO Children, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope in children requiring growth hormone treatment

open access: yesTherapeutic Advances in Endocrinology and Metabolism, 2013
Objective: To describe the rationale, design and first data from PATRO Children, a postmarketing surveillance of the long-term efficacy and safety of somatropin (Omnitrope ® ) for the treatment of children requiring growth hormone treatment.
Roland Pfäffle   +7 more
doaj   +1 more source

Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids. [PDF]

open access: yes, 2019
Tramadol is one of the most commonly used analgesics worldwide, classified as having a low abuse potential by U.S. Drug Enforcement Agency, and often recommended in pain management guidelines.
Abagyan, Ruben   +3 more
core   +1 more source

Clinical perspectives of emerging pathogens in bleeding disorders. [PDF]

open access: yes, 2006
As a result of immunological and nucleic-acid screening of plasma donations for transfusion-transmissible viruses, and the incorporation of viral reduction processes during plasma fractionation, coagulation-factor concentrates (CFC) are now judged safe ...
Bozzette, Samuel   +11 more
core   +1 more source

Glycoprotein IIb/IIIa Inhibitors Use and Outcome after Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction [PDF]

open access: yes, 2014
Aims. We investigate the effect of glycoprotein IIb/IIIa (GP IIb/IIIa) inhibitors on long-term outcomes following percutaneous coronary intervention (PCI) after non-ST elevation myocardial infarction (NSTEMI). Meta-analyses indicate that these agents are
Antoniou, S   +9 more
core   +4 more sources

Postmarket Surveillance of Medical Devices: A Comparison of Strategies in the US, EU, Japan, and China [PDF]

open access: yes, 2013
Daniel Kramer and colleagues compare strategies for postmarket surveillance of medical devices and discuss ways to improve these systems.
Kesselheim, Aaron S.   +3 more
core   +2 more sources

Development of instrument to report and asses causality of adverse events related to herbal medicines

open access: yesVitae, 2017
Background: The use of herbal medicines is justified empirically using ethnopharmacological knowledge, which has limitations. Reports of adverse events (AE) may contribute for safety, quality, and effectiveness assessment. Objectives: This study aimed to
Patricia de Carvalho MASTROIANNI   +3 more
doaj  

Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis [PDF]

open access: yes, 2012
Objective Systemic juvenile idiopathic arthritis (JIA) is characterized by fevers, rash, and arthritis, for which interleukin‐1 (IL‐1) and IL‐6 inhibitors appear to be effective treatments.
Carol A. Wallace   +19 more
core   +1 more source

Effects of RANKL-Targeted Therapy in Immunity and Cancer. [PDF]

open access: yes, 2014
The role of the receptor activator of nuclear factor-κB ligand (RANKL)/RANK system is well characterized within bone, where RANKL/RANK signaling mediates osteoclastogenesis and bone resorption.
Cheng, Michael L, Fong, Lawrence
core   +2 more sources

National Pharmacovigilance Assessment of Oral Adverse Events Following COVID-19 Vaccination in Germany (2020-2023)

open access: yesInternational Dental Journal
Objectives: Pharmacovigilance efforts for COVID-19 vaccines have largely focused on severe adverse events (AEs), while nonserious, yet distressing, AEs, such as oral AEs, remain underexamined. This study aimed to analyse oral AE reporting patterns in the
Abanoub Riad
doaj   +1 more source

Home - About - Disclaimer - Privacy